Movember Launches Projects Under the Global Action Plan (GAP)
Movember has announced the launch of two supplementary projects under the Global Action Plan (GAP) prostate cancer biomarker initiative – The GAP1 xenograft project and the GAP1 Unique TMAs project.
Movember has released a global “Expression of Interest” to identify and engage interested researchers with relevant expertise in these two research areas.
The information received during the EOI process will be used to create trans-national multi-disciplinary teams who will collaborate to answer key clinical questions.
• Investigators interested in the GAP1 Xenograft project should email Movember at email@example.com and note that the EOI closes on the 1st February 2013.
• Investigators interested in the GAP1 Unique TMA’s project should email Movember at firstname.lastname@example.org and note that the EOI closes on the 28th February 2013